Succinylcholine is a depolarizing skeletal muscle relaxant consisting of two molecules of the endogenous neurotransmitter acetylcholine (ACh) linked by their acetyl groups. It has been widely used for over 50 years, most commonly in its chloride salt form, as a means of neuromuscular blockade during intubation and surgical procedures. Its rapid onset and offset, with effects beginning within 60 seconds of intravenous administration and lasting between four to six minutes, make succinylcholine particularly useful in the setting of short medical procedures requiring brief periods of muscle relaxation.
Succinylcholine is indicated as an adjunct to general anesthesia, to facilitate tracheal intubation, and to provide skeletal muscle relaxation during surgery or mechanical ventilation.
Bispebjerg Hospital, Copenhagen, Denmark
Rigshospitalet, Copenhagen, Denmark
Department of Anaesthesiology, Pain and Respiratory Support, Rigshospitalet Glostrup, Glostrup, Denmark
National Taiwan University Hospital, Taipei, Taiwan
Herlev Hospital, Herlev, Denmark
Fédération d'anesthésie-réanimation - Hôpital Pontchaillou, CHU de Rennes, Rennes, France
Service d'anesthésie-réanimation - Fondation A. de Rothschild, Paris, France
Département d'anesthésie-réanimation - Hôpital de la Cavale Blanche, CHU de Brest, Brest, France
University of Chicago Medicine, Chicago, Illinois, United States
University of Toledo, Health Science Campus, Toledo, Ohio, United States
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.